BTL Industries is a privately owned company established in 1993, focusing on the development and manufacture of Physiotherapy, Cardiology, and Aesthetic Equipment. With a vast global presence, it operates in more than 85 countries across 5 continents with over 3800 employees and 400 R&D engineers.
Its key segments encompass cardiology, pneumology, physical therapy, and medical aesthetics. Notably, its medical aesthetic line offers non-invasive body shaping technologies and advanced systems for skin tightening, cellulite treatment, hair removal, and facial therapies.
BTL conducts worldwide marketing through direct sales subsidiaries in over 70 countries and an extensive network of independent distributors. Its US sales are based in Boston, Massachusetts. The company prides itself on its world-class ISO 13485 certified quality system and GMP compliance. Furthermore, many of its products are CE marked, US FDA cleared, and Health Canada licensed.
While specific details on the headquarters and recent investments are not available, BTL Industries' comprehensive product range and its global reach position it as a significant player in the Industrial, Manufacturing, and Medical Devices industries.
There is no investment information
No recent news or press coverage available for BTL Industries.